Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

15.78 -0.67 (-4.07%)

Streaming Delayed Price Updated: 12:46 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

51 52 Next >

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health ↗

March 05, 2025

The news slammed Hims stock. Hims & Hers sells knockoff versions of semaglutide, the chemical backbone behind Wegovy.

Via Investor's Business Daily

Missed the Hims & Hers Rally? Clover Health Could Be Next

March 05, 2025

After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space.

Via MarketBeat

EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank? ↗

March 04, 2025

These were the 20 tickers that Benzinga readers searched for the most during the month of February.

Via Benzinga

Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath ↗

March 04, 2025

U.S. markets suffered a steep selloff Monday as President Donald Trump announced sweeping new tariffs, extending last week's losses and driving declines across all major sectors.

Via Benzinga

Topics Government World Trade

Why Hims & Hers Health Stock Sank This Week ↗

February 28, 2025

Via The Motley Fool

Short Term Relief Likely ↗

March 02, 2025

Post earnings has seen little bullish follow-through, and this typically means the broad market won’t have much to shout about over the coming weeks.

Via Talk Markets

Topics ETFs Stocks / Equities

Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? ↗

March 01, 2025

Via The Motley Fool

Sixty Percent Of The Time, It Works Every Time ↗

February 28, 2025

The past few weeks have brought a dramatic change in investor sentiment.

Via Talk Markets

Topics Stocks / Equities

Hims & Hers Health Unusual Options Activity For February 28 ↗

February 28, 2025

Via Benzinga

Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up ↗

February 28, 2025

Can Hims & Hers Health recover after the FDA removed semaglutide from its drugs shortage list?

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Hims Stock Crashed After Earnings. What Went Wrong? ↗

February 25, 2025

Via The Motley Fool

NVDA Earnings And The State Of The Market ↗

February 26, 2025

Nvidia reported its much anticipated 4Q earnings after the close. It was a mixed bag.

Via Talk Markets

Topics Stocks / Equities

Why Hims & Hers Stock Rebounded on Wednesday ↗

February 26, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 26, 2025

Via Benzinga

Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now

February 26, 2025

See why these two high-flying stocks are among the most shorted in the market, plus counterarguments amid bearish gripes.

Via MarketBeat

GoodRx Earnings: What To Look For From GDRX

February 26, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know.

Via StockStory

Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings ↗

February 25, 2025

Via Benzinga

Topics Stocks

Hims & Hers Health Analyst Sees Buying Opportunity Following Steep Selloff: 'We See No Reason To Change Our View' ↗

February 25, 2025

Hims & Hers Health Inc. (NYSE: HIMS) shares dropped sharply after the company reported its fourth-quarter earnings. Here's what you need to know.

Via Benzinga

Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today

February 25, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected,...

Via StockStory

Which stocks are experiencing notable movement on Tuesday? ↗

February 25, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday? ↗

February 25, 2025

Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a...

Via Benzinga

Topics Stocks

Hims & Hers Stock Crashed 26% Today. Here's What You Need to Know ↗

February 25, 2025

Hims & Hers grew 95% in the fourth quarter of 2024, but investors were worried about GLP-1 growth.

Via The Motley Fool

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

February 25, 2025

Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Hims & Hers Health Stock Is Plunging Tuesday: What's Going On? ↗

February 25, 2025

Hims & Hers Health reported fourth-quarter revenue of $481.14 million, beating estimates of $470.31 million, according to Benzinga Pro. The company reported fourth-quarter earnings of 11 cents per...

Via Benzinga

What's going on in today's pre-market session ↗

February 25, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

February 25, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Via StockStory

Markets Mostly Dip Red Late In Regular Trading ↗

February 24, 2025

Market indexes drooped in the final minutes of the normal trading day to start a new week, with all major indexes save the blue-chip Dow closing in the red, adding to Friday’s losses.

Via Talk Markets

Topics Stocks Stocks / Equities

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

What's going on in today's after hours session ↗

February 24, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.